SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-055738
Filing Date
2021-11-09
Accepted
2021-11-09 16:16:00
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K annx-8k_20211109.htm   iXBRL 8-K 39827
2 EX-99.1 annx-ex991_6.htm EX-99.1 285613
3 GRAPHIC geltxasjxhgo000001.jpg GRAPHIC 86282
  Complete submission text file 0001564590-21-055738.txt   591111

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA annx-20211109.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20211109_lab.xml EX-101.LAB 20069
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20211109_pre.xml EX-101.PRE 11928
7 EXTRACTED XBRL INSTANCE DOCUMENT annx-8k_20211109_htm.xml XML 3677
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 211392394
SIC: 2834 Pharmaceutical Preparations